Pre-exposure prophylaxis regimens for HIV (6), (7)
| Regimen type | Available regimens | Population |
|---|---|---|
| Daily PrEP | Tenofovir disoproxil/emtricitabine (TDF/FTC) 1 tablet daily administered orally | All populations |
| Tenofovir alafenamide/emtricitabine (TAF/FTC) 1 tablet daily administered orally | Sexual exposures excluding receptive vaginal intercourse | |
| On-demand PrEP | Tenofovir disoproxil/emtricitabine (TDF/FTC) 2 tablets administered orally 2–24 h before first exposure and then once daily for 48 h after last exposure | GBM and transgender women |
Note: GBM = gay, bisexual and other men who have sex with men, PrEP = pre-exposure prophylaxis.